Uncategorized

BioNTech picks Sobi CEO Oelkers to lead as founders plot new mRNA biotech

Published

on

BioNTech’s leadership transition was announced earlier this year, with CEO Ugur Sahin and CMO Özlem Türeci leaving to start a new mRNA company. Guido Oelkers of Swedish Orphan Biovitrum AB will take over as CEO in early 2027.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version